AssayQuant Technologies, Inc.
PrivateLast Round
Grant
Aug 15, 2024
Total Funding Raised
$5.59M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
AssayQuant Technologies, Inc. is a discovery tools company that develops and commercializes real-time, continuous enzyme activity assays, reagents, and services for drug discovery research.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Biotech Equipment
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
AssayQuant Technologies, Inc. Comparables
Compare AssayQuant Technologies, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| BellBrook Labs | 84% | |
| SIRION Biotech | 77% | |
| BPS Bioscience | 76% |
AssayQuant Technologies, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Aug 15, 2024 | ||||
| VC Round | Mar 12, 2024 | ||||
| VC Round | Oct 1, 2023 | ||||
| Convertible Debt | Jul 12, 2023 | ||||
| Angel | May 14, 2021 |
Key People
Founding team and executive leadership
AssayQuant Technologies, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Cancer Institute | Grant |
| NIH RADx | Grant |
| Future Labs Capital | Series B, VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 22, 2026
Monthly visitors grew 94% MoM, from 4.2K to 8.2K.
- Dec 9, 2025
Added BIOMEDICA Medizinprodukte GmbH, a medical device distributor, as a customer.
AssayQuant Technologies, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about AssayQuant Technologies, Inc.'s valuation, stock price, and market status.
Is AssayQuant Technologies, Inc. a public or private company?
AssayQuant Technologies, Inc. is a private company.
What is the current stock price of AssayQuant Technologies, Inc.?
AssayQuant Technologies, Inc. is a private company, so its shares have no public market price. Caplight tracks AssayQuant Technologies, Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is AssayQuant Technologies, Inc. worth (valuation)?
Valuation information for AssayQuant Technologies, Inc. is not publicly available.
Can I buy AssayQuant Technologies, Inc. stock?
AssayQuant Technologies, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was AssayQuant Technologies, Inc.'s last funding round?
AssayQuant Technologies, Inc.'s most recent funding round was Grant on August 15, 2024.
Who are the main investors in AssayQuant Technologies, Inc.?
Key investors in AssayQuant Technologies, Inc. include Future Labs Capital.
Will AssayQuant Technologies, Inc. IPO soon?
No public IPO plans have been announced for AssayQuant Technologies, Inc..
How can I track AssayQuant Technologies, Inc. secondary market activity?
Caplight tracks bids, offers, and trades in AssayQuant Technologies, Inc.'s shares on secondary markets.